ArticleOxidative medicine and cellular longevity2022

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types.

Aimin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.